October

ERJ Podcast Eur Respir J 2012; 40: E22
Unfolding the mechanisms of progression of pulmonary emphysema in COPD}, Pellegrino R., Antonelli A. Eur Respir J 2012; 40: 801-803
Euthanasia: from ethical debate to clinical reality}, Berghmans T., Lossignol D. Eur Respir J 2012; 40: 804-805
Presenting the European Forum for TB Innovation: innovative thinking in progressing towards TB elimination in Europe}, Blasi F., Reichman L.B., Migliori G.B. Eur Respir J 2012; 40: 806-808
Towards a total ban on links with the tobacco industry: new rules for the ERS}, Rabe K.F., Gratziou C., Ward B., Berteletti F. Eur Respir J 2012; 40: 809-810
Dr Solbert Permutt, 1925–2012}, Mitzner W., Sylvester J.T. Eur Respir J 2012; 40: 811-813
Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones}, Migliori G.B., Langendam M.W., D'Ambrosio L., Centis R., Blasi F., Huitric E., Manissero D., van der Werf M.J. Eur Respir J 2012; 40: 814-822
The EvA study: aims and strategy}, Ziegler-Heitbrock L., Frankenberger M., Heimbeck I., Burggraf D., Wjst M., Häussinger K., Brightling C., Gupta S., Parr D., Subramanian D., Singh D., Kolsum U., Boschetto P., Potena A., Gorecka D.. Nowinski A., Barta I., Döme B., Strausz J., Greulich T., Vogelmeier C., Bals R., Hohlfeld J.M., Welte T., Venge P., Gut I., Boland A., Olaso R., Hager J., Hiemstra P., Rabe K.F., Unmüßig M., Müller-Quernheim J., Prasse A. Eur Respir J 2012; 40: 823-829
Efficacy and safety of twice-daily aclidinium bromide in COPD patients: the ATTAIN study}, Jones P.W., Singh D., Bateman E.D., Agusti A., Lamarca R., de Miquel G., Segarra R., Caracta C., E.G. Gil Eur Respir J 2012; 40: 830-836
Increased oxygen pulse after lung volume reduction surgery is associated with reduced dynamic hyperinflation}, Lammi M.R., Ciccolella D., Marchetti N., Kohler M., Criner G.J. Eur Respir J 2012; 40: 837-843
Computed tomography-quantified emphysema distribution is associated with lung function decline}, Mohamed H., Firdaus A.A., van Rikxoort E., van Ginneken B., de Jong P.A., Prokop M., Lammers J.-W.J., Zanen P. Eur Respir J 2012; 40: 844-850
Does oxidative stress modulate limb muscle atrophy in severe COPD patients?}, Fermoselle C., Rabinovich R., Ausín P., Puig-Vilanova E., Coronell C., Sanchez F., Roca J., Gea J., Barreiro E. Eur Respir J 2012; 40: 851-862
Reduced nuclear factor-?B repressing factor: a link toward systemic inflammation in COPD}, Lee K.-Y., Ho S.-C., Chan Y.-F., Wang C.-H., Huang C.-D., Liu W.-T., Lin S.-M., Lo Y.-L., Chang Y.-L., Kuo L.-W., Kuo H.-P. Eur Respir J 2012; 40: 863-873
Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension}, Simonneau G., Torbicki A., Hoeper M.M., Delcroix M., Karlócai K., Galiè N., Degano B., Bonderman D., Kurzyna M., Efficace M., Giorgino R., Lang I.M. Eur Respir J 2012; 40: 874-880
Pregnancy outcomes in pulmonary arterial hypertension in the modern management era}, Jaïs X., Olsson K.M., Barbera J.A., Blanco I., Torbicki A., Peacock A., Vizza C.D., Macdonald P., Humbert M., Hoeper M.M. Eur Respir J 2012; 40: 881-885
Effects of C-reactive protein on human pulmonary vascular cells in chronic thromboembolic pulmonary hypertension}, Wynants M., Quarck R., Ronisz A., Alfaro-Moreno E., Van Raemdonck D., Meyns B., Delcroix M. Eur Respir J 2012; 40: 886-894
Leptin and regulatory T-lymphocytes in idiopathic pulmonary arterial hypertension}, Huertas A., Tu L., Gambaryan N., Girerd B., Perros F., Montani D., Fabre D., Fadel E., Eddahibi S., Cohen-Kaminsky S., Guignabert C., Humbert M. Eur Respir J 2012; 40: 895-904
Serial computed tomography and lung function testing in pulmonary Langerhans’ cell histiocytosis}, Tazi A., Marc K., Dominique S., de Bazelaire C., Crestani B., Chinet T., Israel-Biet D., Cadranel J., Frija J., Lorillon G., Valeyre D., Chevret S. Eur Respir J 2012; 40: 905-912
Effects of 8 weeks of continuous positive airway pressure on abdominal adiposity in obstructive sleep apnoea}, Sivam S., Phillips C.L., Trenell M.I., Yee B.J., Liu P.Y., Wong K.K., Grunstein R.R. Eur Respir J 2012; 40: 913-918
Sleep-disordered breathing in deep vein thrombosis and acute pulmonary embolism}, Arzt M., Luigart R., Schum C., Lüthje L., Stein A., Koper I., Hecker C., Dumitrascu R., Schulz R., for the “Circulation, Sleep” working group of the German Society of Sleep Research, Sleep Medicine (DGSM) Eur Respir J 2012; 40: 919-924
Social determinants of tuberculosis in Europe: a prospective ecological study}, Ploubidis G.B., Palmer M.J., Blackmore C., Lim T.-A., Manissero D., Sandgren A., Semenza J.C. Eur Respir J 2012; 40: 925-930
Community-acquired pneumonia in outpatients: aetiology and outcomes}, Cillóniz C., Ewig S., Polverino E., Marcos Maria A., Prina E., Sellares J., Ferrer M., Ortega M., Gabarrús A., Mensa J., Torres A. Eur Respir J 2012; 40: 931-938
Pre-treatment with mesenchymal stem cells reduces ventilator-induced lung injury}, Chimenti L., Luque T., Bonsignore M.R., Ramírez J., Navajas D., Farré R. Eur Respir J 2012; 40: 939-948
Expressed wishes and incidence of euthanasia in advanced lung cancer patients}, Pardon K., Deschepper R., Vander Stichele R., Bernheim J.L., Mortier F., Schallier D., Germonpré P., Galdermans D., Van Kerckhoven W., Deliens L. Eur Respir J 2012; 40: 949-956
Radiotherapy and chemotherapy for elderly patients with stage I–II unresected lung cancer}, Wisnivesky J.P., Bonomi M., Lurslurchachai L., Mhango G., Halm E.A. Eur Respir J 2012; 40: 957-964
Mesothelioma incidence projections in South East England}, Riaz S.P., Coupland V.H., Lüchtenborg M., Peake M.D., Møller H. Eur Respir J 2012; 40: 965-968
Efficacy, safety and effect on biomarkers of AZD9668 in cystic fibrosis}, Elborn J.S., Perrett J., Forsman-Semb K., Marks-Konczalik J., Gunawardena K., Entwistle N. Eur Respir J 2012; 40: 969-976
Measurement of parasternal intercostal electromyogram during an infective exacerbation in patients with cystic fibrosis}, Reilly C.C., Jolley C.J., Elston C., Moxham J., Rafferty G.F. Eur Respir J 2012; 40: 977-981
The mechanism of deep inspiration-induced bronchoprotection: evidence from a mouse model}, Wong R.S., Larcombe A.N., Fernandes L.B., Zosky G.R., Noble P.B. Eur Respir J 2012; 40: 982-989
The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement}, Bumbacea D., Arend S.M., Eyuboglu F., Fishman J.A., Goletti D., Ison M.G., Jones C.E., Kampmann B., Kotton C.N., Lange C., Ljungman P., Milburn H., Morris M.I., Muller E., Muñoz P., Nellore A., Rieder H.L., Sester U., Theodoropoulos N., Wagner D., Sester M. Eur Respir J 2012; 40: 990-1013
Novel approaches to the treatment of Pseudomonas aeruginosa infections in cystic fibrosis}, Hurley M.N., Cámara M., Smyth A.R. Eur Respir J 2012; 40: 1014-1023
Nitric oxide in primary ciliary dyskinesia}, Walker W.T., Jackson C.L., Lackie P.M., Hogg C., Lucas J.S. Eur Respir J 2012; 40: 1024-1032
Respiratory health and indoor air pollutants based on quantitative exposure assessments}, Hulin M., Simoni M., Viegi G., Annesi-Maesano I. Eur Respir J 2012; 40: 1033-1045
Reduced plasma fetuin-A levels in patients with obstructive sleep apnoea}, Barceló A., Piérola J., Esquinas C., de la Peña M., Arqué M., la Torre M.S., Alonso-Fernandez A., Barbé F. Eur Respir J 2012; 40: 1046-1048
Chronic cough and obstructive sleep apnoea: reflux-associated cough hypersensitivity?}, Faruqi S., Fahim A., Morice A.H. Eur Respir J 2012; 40: 1049-1050
Moxifloxacin in multidrug-resistant tuberculosis: is there any indication for therapeutic drug monitoring?}, Manika K., Chatzika K., Zarogoulidis K., Kioumis I. Eur Respir J 2012; 40: 1051-1053
An uncommon reason for dyspnoea: phrenic paresis secondary to alveolar echinococcosis}, Wassmer P., Chronis J., Rüdiger J.J., Boggian K. Eur Respir J 2012; 40: 1053-1055
Protease-activated receptor-4 deficiency does not protect against bleomycin-induced pulmonary fibrosis in mice}, Borensztajn K., Duitman J., Brüggemann L.W., Spek C.A. Eur Respir J 2012; 40: 1056-1057
Severe pulmonary hypertension leading to heart–lung transplantation and revealing breast cancer}, Madjer T., Danner-Boucher I., Horeau-Langlard D., Haloun A., Lepoivre T., Sagan C., Magnan A. Eur Respir J 2012; 40: 1057-1059
Long-term follow-up of children with congenital chylothorax}, Resch B., Halmer M., Müller W.D., Eber E. Eur Respir J 2012; 40: 1060-1062
Diagnosing COPD and targeted lung cancer screening}, Young R.P., Hopkins R.J. Eur Respir J 2012; 40: 1063-1064